Thoughts on COVID-19 and autoimmune diseases
10.1136/lupus-2020-000396
April 3, 2020
Most Read Articles
Interferon pathway in SLE: one key to unlocking the mystery of the disease
10.1136/lupus-2018-000270
August 13, 2019
Prediction of prognosis and renal outcome in lupus nephritis
10.1136/lupus-2020-000389
February 18, 2020
Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice
10.1136/lupus-2020-000387
April 16, 2020
Low hydroxychloroquine blood levels in patients who have had gastric bypass surgery
10.1136/lupus-2019-000335
June 16, 2019
Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA
10.1136/lupus-2019-000357
March 26, 2020
Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures
10.1136/lupus-2019-000365
December 30, 2019
Utility of the AVISE Connective Tissue Disease test in predicting lupus diagnosis and progression
10.1136/lupus-2019-000345
March 18, 2020
String of successful trials in SLE: have we cracked the code?
10.1136/lupus-2019-000380
January 2, 2020
First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study
10.1136/lupus-2019-000354
November 9, 2019